FAIR VALUE MEASUREMENT - Narrative (Details) $ / shares in Units, $ / shares in Units, $ in Thousands, $ in Millions		3 Months Ended		6 Months Ended		12 Months Ended
	Mar. 02, 2021 USD ($)	Jun. 30, 2024 USD ($)	Jun. 30, 2023 USD ($)	Jun. 30, 2024 USD ($)	Jun. 30, 2023 USD ($)	Dec. 31, 2021 USD ($)	Dec. 31, 2023 USD ($)	Apr. 06, 2023 USD ($) $ / shares shares	Nov. 14, 2022 USD ($)	Nov. 14, 2022 CAD ($) $ / shares
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Gain on initial investment in unconsolidated entity		$ 0	$ 10,700	$ 0	$ 10,700
Gain on fair value of financial instruments		1,140	4,229	(720)	9,612
Investment in unconsolidated entity		11,200		11,200			$ 11,000
Debt interest rate conversion feature		691		691			872
Derivative liability, noncurrent		2,892		2,892			3,213
Purchase option	$ 8,000					$ 8,000
Purchase option, term						5 years
Extension, term						2 years
Percentage of outstanding shares						10.00%
Warrants expiration period						60 days
Gain (loss) on change in fair value of purchase option		(34)	57	(985)	(243)
Financial asset, purchase option		745		745			1,730
BAT Group
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Convertible ownership percentage									19.90%	19.90%
Conversion price (in CAD per share) | $ / shares										$ 2.00
BAT Group | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Accrued interest rate, percentage									5.00%	5.00%
BAT Group | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Accrued interest rate, percentage									1.50%	1.50%
BAT Group | Convertible Notes Payable
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Principal Amount		59,668		59,668			60,116		$ 56,800	$ 75.3
DeFloria, LLC
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Equity method ownership percentage								50.00%
British American Tobacco | DeFloria, LLC
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Preferred units ownership percentage								100.00%
AJNA Biosciences | DeFloria, LLC
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Equity method ownership percentage								50.00%
DeFloria, LLC
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Common units (in shares) | shares								400,000
Gain on fair value of financial instruments		1,000	0	200	0
Investment in unconsolidated entity		11,200		11,200			11,000
DeFloria, LLC | Class A Common Stock
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants outstanding (in shares) | shares								865,052
Warrants exercise price (in USD per share) | $ / shares								$ 2.89
DeFloria, LLC | British American Tobacco
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Preferred units (in shares) | shares								200,000
Capital contributed								$ 10,000
Payment for convertible debt				5,000
DeFloria, LLC | AJNA Biosciences
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Payment for convertible debt				2,000
Common units (in shares) | shares								400,000
Debt Conversion Option
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Unrealized gain (loss) on hedging instruments		276	4,066	220	10,361
Derivative liability, noncurrent		2,892		2,892			3,213
Level 3
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment in unconsolidated entity		11,200		11,200
Debt interest rate conversion feature		691		691			872
Derivative liability, noncurrent		0		0			0
Financial asset, purchase option		745		745			$ 1,730
Debt Interest Rate Conversion Feature
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Unrealized gain (loss) on hedging instruments		$ (101)	$ 106	$ (154)	$ (506)